13D/13G Filings - Eventide Asset Management, LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, 3, 4, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-05-15
4:45 pm
Purchase
2025-05-0913GInventiva S.A.
IVA
Eventide Asset Management, LLC10,118,517
6.700%
10,118,517increase
(New Position)
Filing
History
2025-05-14
4:04 pm
Purchase
2025-03-3113GEvolent Health, Inc.
EVH
Eventide Asset Management, LLC6,077,191
5.200%
6,077,191increase
(New Position)
Filing
History
2025-05-14
3:51 pm
Unchanged
2025-03-3113GZentalis Pharmaceuticals, Inc.
ZNTL
Eventide Asset Management, LLC0
0.000%
0
(Unchanged)
Filing
History
2025-05-14
3:28 pm
Unchanged
2025-03-3113GAura Biosciences, Inc.
AURA
Eventide Asset Management, LLC0
0.000%
0
(Unchanged)
Filing
History
2025-05-13
5:30 pm
Sale
2025-03-3113GZentalis Pharmaceuticals, Inc.
ZNTL
Eventide Asset Management, LLC0
0.000%
-4,475,054decrease
(Position Closed)
Filing
History
2025-05-13
5:28 pm
Sale
2025-03-3113GAura Biosciences, Inc.
AURA
Eventide Asset Management, LLC0
0.000%
-4,080,605decrease
(Position Closed)
Filing
History
2025-04-23
10:28 am
Sale
2024-12-3113GInozyme Pharma, Inc.
INZY
Eventide Asset Management, LLC2,220,000
3.460%
-1,914,436decrease
(-46.30%)
Filing
History
2025-02-14
12:13 pm
Sale
2024-12-3113GZentalis Pharmaceuticals, Inc.
ZNTL
Eventide Asset Management, LLC4,475,054
6.280%
-2,615,054decrease
(-36.88%)
Filing
History
2025-02-14
12:11 pm
Sale
2024-12-3113GXometry, Inc.
XMTR
Eventide Asset Management, LLC3,151,897
6.720%
-1,266,767decrease
(-28.67%)
Filing
History
2025-02-14
12:08 pm
Sale
2024-12-3113GNektar Therapeutics
NKTR
Eventide Asset Management, LLC6,650,000
3.610%
-2,750,000decrease
(-29.26%)
Filing
History
2025-02-14
12:06 pm
Sale
2024-12-3113GMirum Pharmaceuticals, Inc.
MIRM
Eventide Asset Management, LLC2,606,938
5.430%
-838,425decrease
(-24.33%)
Filing
History
2025-02-14
12:03 pm
Sale
2024-12-3113GLexeo Therapeutics, Inc. Common Stock
LXEO
Eventide Asset Management, LLC1,234,834
3.730%
-621,152decrease
(-33.47%)
Filing
History
2025-02-14
12:01 pm
Purchase
2024-12-3113GInozyme Pharma, Inc.
INZY
Eventide Asset Management, LLC2,220,000
3.460%
2,220,000increase
(New Position)
Filing
History
2025-02-14
11:56 am
Sale
2024-12-3113GAura Biosciences, Inc.
AURA
Eventide Asset Management, LLC4,080,605
8.170%
-1,722,077decrease
(-29.68%)
Filing
History
2025-02-05
5:59 pm
Purchase
2025-01-3113GBeta Bionics, Inc.
BBNX
Eventide Asset Management, LLC4,857,041
11.320%
4,857,041increase
(New Position)
Filing
History
2024-11-14
12:27 pm
Sale
2024-09-3013GXometry, Inc.
XMTR
Eventide Asset Management, LLC4,418,664
9.480%
-1,309,106decrease
(-22.86%)
Filing
History
2024-11-14
12:25 pm
Purchase
2024-09-3013GMirum Pharmaceuticals, Inc.
MIRM
Eventide Asset Management, LLC3,445,363
7.220%
751,782increase
(+27.91%)
Filing
History
2024-11-14
12:24 pm
Sale
2024-09-3013GMarinus Pharmaceuticals, Inc.
MRNS
Eventide Asset Management, LLC0
0.000%
-4,529,997decrease
(Position Closed)
Filing
History
2024-11-14
12:23 pm
Sale
2024-09-3013GLexeo Therapeutics, Inc. Common Stock
LXEO
Eventide Asset Management, LLC1,855,986
5.610%
-336,225decrease
(-15.34%)
Filing
History
2024-11-14
12:21 pm
Sale
2024-09-3013GKorro Bio, Inc.
KRRO
Eventide Asset Management, LLC391,166
4.210%
-155,159decrease
(-28.40%)
Filing
History
Goto 0, 1, 2, 3, 4, Next